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Abstract
Background: In Uganda, parasite-based diagnosis is recommended for every patient suspected to have malaria
before prescribing anti-malarials. However, the majority of patients are still treated presumptively especially in low-
level health units. The feasibility of implementing parasite-based diagnosis for uncomplicated malaria in rural health
centres (HCs) was investigated with a view to recommending measures for scaling up the policy.
Methods: Thirty HCs were randomized to implement parasite-based diagnosis based on rapid diagnostic tests
[RDTs] (n = 10), blood microscopy (n = 10) and presumptive diagnosis (control arm) (n = 10). Feasibility was
assessed by comparing the proportion of patients who received parasite-based diagnosis; with a positive malaria
parasite-based diagnosis who received artemether-lumefantrine (AL); with a negative malaria parasite-based
diagnosis who received AL; and patient waiting time. Clinicaltrials.gov: NCT00565071.
Results: 102, 087 outpatients were enrolled. Patients were more likely to be tested in the RDT 44, 565 (96.6%) than
in microscopy arm 19, 545 (60.9%) [RR: 1.59]. RDTs reduced patient waiting time compared to microscopy and
were more convenient to health workers and patients. Majority 23, 804 (99.7%) in presumptive arm were
prescribed AL. All (100%) of patients who tested positive for malaria in RDT and microscopy arms were prescribed
anti-malarials. Parasitological-based diagnosis significantly reduced AL prescription in RDT arm [RR: 0.62] and
microscopy arm [RR: 0.72] compared to presumptive treatment. Among patients not tested in the two intervention
arms, 12, 044 (96.1%) in microscopy and 965 (61.6%) in RDT arm were treated with AL [RR: 1.56]. Overall 10, 558
(29.4%) with negative results [5, 110 (23.4%) in RDT and 5, 448 (39.0%) in microscopy arms] were prescribed AL.
Conclusion: It was more feasible to implement parasite-based diagnosis for malaria using RDT than with
microscopy. A high proportion of patients with negative malaria results are still prescribed anti-malarials. There is
need to increase access to parasite-based diagnosis where microscopy is used. In order to fully harness the
benefits of parasitological confirmation of malaria, it is necessary to reduce the prescription of anti-malarials in
negative patients.
Background
Malaria presents a diagnostic challenge in most endemic
countries in sub-Saharan Africa, yet early diagnosis and
appropriate treatment is a basic tenet of current malaria
policy [1]. In sub-Saharan Africa, documentation of
fever or history of fever has traditionally been consid-
ered sufficient evidence for prescribing anti-malarial
therapy [2-4]. This presumptive diagnostic technique is
inaccurate [5-8] and results in over diagnosis and over
treatment. Further, because of the inaccuracies asso-
ciated with presumptive treatment, decline in the pro-
portion of fevers attributable to malaria, and use of
expensive anti-malarials such as artemisinin-based com-
bination therapy (ACT) [4,9-11], the World Health
Organization (WHO) [1] now recommends parasite-
based confirmation of parasitaemia before prescription
of ACT.
The role of laboratory diagnosis of malaria is primarily
to support clinical care [12], and the current reference
standard for confirmatory presence of parasitaemia is
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microscopy. However, implementation of routine
malaria microscopy is a challenge. Maintaining good
quality, effective microscopy service requires an orga-
nized health system infrastructure, including the provi-
sion of high-quality supplies and reagents, presence of
satisfactory microscopes, availability of microscopists,
maintenance and technical competence of microscopists,
an adequate workplace environment and the ability to
prepare usable blood films. Field microscopy where
established, often falls short of these requirements
[13-15]. In Uganda, there is shortage of staff, especially
laboratory personnel to perform microscopy [16].
Because parasite detection is performed by someone
other than the prescriber, there is a tendency to ignore
microscopy results provided by the laboratory [2-4]. Yet
health workers’ adherence to diagnostic and treatment
guidelines is a critical aspect in determining effective
implementation of malaria case management policies
[17,18]. To put testing and clinical decisions in the hands
of the prescriber, the use of malaria rapid diagnostic tests
(RDTs) has been encouraged [1,7,10,15] as an integral
part of widespread deployment of ACT. In line with
international recommendations, Uganda introduced arte-
mether-lumefantrine (AL) as first-line treatment for
uncomplicated malaria in 2006, and commenced a
phased role-out of a histidine rich protein-2 (HRP-2)-
based RDT as an alternative to microscopy in primary
level health centres (HCs) in 2008. However, quality
parasite-based diagnosis remains unavailable to most
outpatients presenting with febrile illness.
Although the sensitivity and specificity of malaria
microscopy and RDTs have been assessed in different
studies [8,19] and the feasibility of RDT in other settings
[20], there has been no study gauging the feasibility of
the use of these diagnostic strategies and whether the
use of parasite-based diagnosis changes prescription of
AL in rural settings in Uganda. The key question is
“given the current standing at sub-county HCs and
available resources, is it possible to test every patient
presenting with febrile illness before treatment? There-
fore the current study compared the feasibility of these
malaria diagnostic techniques in rural government HCs
located within areas of varying transmission intensities
in Uganda. The main outcome measures were: propor-
tion of febrile outpatients receiving a malaria test, pro-
portion of those with negative results treated with AL
and waiting time.
Methods
Study design
This stratified cluster randomized trial (Clinicaltrials.gov:
NCT00565071) was implemented in 15 out of 20 sub-
county government HCs randomly selected in a district
of low and 15 in a district of high malaria transmission
intensity from March 2010 to July 2011. Stratification
was based on transmission intensity. HCs were the pri-
mary sampling units. In each district, HCs were rando-
mized to two intervention arms (microscopy and RDT)
and control arm (presumptive diagnosis), resulting into
five HCs per arm. This trial took a cluster design to
avoid contamination between control and intervention
group subjects and to allow service providers to operate
as they would normally on a day-to-day basis.
Setting
The trial was carried out in Bushenyi and Iganga dis-
tricts in Uganda, and commenced before the two dis-
tricts were partitioned. However, partitioning did not
affect the delivery of health services by the time the
study was closed. Bushenyi district has a population of
731, 392. The district experiences low and unstable
malaria transmission, with people of all ages being at
risk. It is epidemic-prone, with occasional malaria out-
breaks occurring shortly after the rains. Iganga district
has a total population of 540, 939 with 15 HCs at sub-
county level. The district experiences very high malaria
transmission intensity. Malaria is the leading cause of
morbidity and outpatient attendance for all age groups.
Additional description of the study setting has been
published elsewhere [16].
Study procedures
Randomization of health centres to the three arms
Health centres were allocated to the three diagnostic arms
following simple randomization. In Bushenyi district, three
of the five HCs randomized to the microscopy arm were
already offering the service. The study strengthened the
laboratory of Kabira HC with a microscope and supplies.
In Iganga district, two HCs were offering microscopy ser-
vices but the study strengthened the laboratory for one
(Nambale HC). In the other three HCs, the posts for
laboratory personnel were already filled although the
laboratories were not functional. Therefore, the district
provided microscopes and laboratory supplies. In the RDT
arm, three selected HCs in Bushenyi district and two in
Iganga had microscopy services. However, RDTs were
introduced and both clinicians and laboratory personnel
were trained. They were informed during training that
their HCs had been randomized to use RDTs. However,
they were free to test patients with microscopy if needed.
In the presumptive arm although one HC in Bushenyi and
two in Iganga had the laboratory assistants post filled, the
laboratories were not functional. They either had no space
or laboratory equipment and supplies.
Delivery of RDTs and artemether-lumefantrine (AL)
Before the study commenced RDTs, AL, laboratory
reagents and supplies from the National Medical Stores
were delivered to the districts medical stores. This was
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meant to integrate the study into the district health ser-
vices delivery system. It was also a strategy for continu-
ity of services from the time of closing the study. RDTs
were packaged in cartons of 1, 000 tests. In each carton,
there were 40 boxes of 25 tests. Also in the box were 25
alcohol swabs, lancets and a 10 ml bottle of clearing
buffer. Each sachet of RDT contained the test device, a
loop for collecting blood and a descant. The study HCs
were to make requisitions for AL, RDTs, and laboratory
supplies together with antibiotics, analgesics and sun-
dries following the usual guidelines. HCs opened up
stock cards for RDTs that were updated regularly.
Training of staff
Clinicians (clinical officers, nurses/midwives and nursing
assistants) and laboratory assistants received a one-day
refresher training on-site. The training and subsequent
study procedures were a scale-up of the activities per-
formed during the assessment of the accuracy of these
diagnostic techniques [8]. All staff members were trained
in theory by re-orienting them to the malaria treatment
policy. In RDT arm, the staff were in addition trained in 1)
finger prick for collection of blood and 2) preparation and
reading of Paracheck®. In the microscopy arm, members
were in addition trained in: 1) finger prick for collection of
blood, 2) thick/thin blood smear preparation, 3) staining
smears, and 4) blood smear reading. In the microscopy
and RDT arms, data collection commenced after inter-
reader reliability reached a very good agreement (kappa
coefficient = 0.97). The staff in HCs with microscopy or
RDT were instructed to treat patients who have positive
results with anti-malarials. Those with negative results
were to receive alternative medications after further
assessment. Staff in the control arm were only re-oriented
to the current malaria treatment guidelines. HC outpatient
registers were modified to record additional variables such
as the presenting complaints, drugs dispensed and to indi-
cate those prescribed but out-of-stock. The trained staff
were charged with training those that were off-duty on the
day of training. Further clarifications were provided during
supervision. Supervision by the study team and the district
laboratory focal persons was carried out weekly during the
first two months and monthly thereafter. The supervisory
visits were aimed at troubleshooting problems related to
the skills of performing an RDT and interpretation of
results, quality of the test, quality of blood smears,
reagents, status of the microscopes and recording of
results. In addition to monthly support supervision, the
district laboratory focal person provided further visits dur-
ing the routine quarterly schedules.
Description of the diagnostic arms
Presumptive (control) arm
Patients presenting with fever (by statement or mea-
sured) were enrolled to receive service without
parasitological confirmation of malaria. Patients were
treated on the basis of signs and symptoms only.
Microscopy arm
Patients were enrolled on the basis of fever (by state-
ment or measured). Microscopy was performed by
laboratory assistants. These laboratory personnel have
two to three years of pre-service training. Thick and
thin blood smears were prepared by finger-prick using
sterile blood lancets on separate frosted slides. Standard
staining was performed using the Field’s stain method.
Laboratory assistants were only familiar with this stain-
ing technique. Blood films were read at magnification
x1, 000. Each film was graded as positive (asexual
malaria parasites seen) or negative (no malaria parasites
seen) based on inspection of 200 fields. Microscopy test
results were recorded in the laboratory registers.
Patients received the results and treatment on the same
day of visit.
Rapid diagnostic test arm
Patients presenting with fever (by statement or mea-
sured) underwent rapid testing with the “Paracheck®“
device (Orchid Biomedical Systems, Goa, India). Para-
check Pf® is based on the detection of histidine rich pro-
tein-2 (Pf HRP-2) produced by Plasmodium falciparum
trophozoites and young gametocytes. The specimens
were drawn by trained clinicians or laboratory assistants
using a simple finger-prick. The test preparation and
interpretation were done following manufacturer’s
instructions and standard operating procedures prepared
for this study. The test was considered positive when
the antigen line was visible in the test window, negative
when only the control band was visible. RDT results
were recorded in the outpatient registers. Also patients
received the results and treatment on that day of visit.
Duration of outpatient visit
The duration of outpatient visit was assessed in six HCs
using a random sample of 1627 consenting patients.
When a patient arrived at the HC, time was recorded by
the research assistant on a “time sheet.” The “time
sheet” was then given to the patient. Thereafter, the
time was recorded by clinicians and laboratory person-
nel at every point of service delivery. The “time sheet”
was finally retained at the dispensing window. For the
laboratory personnel, the effective contact time was
comprised of: drawing a sample from the patient, slide
preparation, scanning the 200 film fields until declaring
a slide negative and reporting of results. With regard to
RDT, the effective contact time was comprised of: draw-
ing blood samples from patients, applying samples onto
the test, test reading and reporting of results.
Overall data collection
Data collection was carried out weekly by the research
assistants by extracting information from the laboratory
and outpatient registers from March 2010 to July 2011.
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Statistical analysis
The collected data were manually checked and cleaned.
Data were double entered by two trained database assis-
tants in a customized entry template with in-built con-
sistency checks in EpiData 3.1 software (The EpiData
Association, Odense, Denmark). The two data sets were
validated to check for entry errors. Before analysis in
Stata version 10 (Stata Corp LP, College Station, Texas,
USA), the data was declared a cluster design using the
“svyset command” with HCs as primary sampling units.
Further, the Poisson regression model was fitted while
accounting for clustering. Probability values (p-values)
were set at 0.05 and confidence intervals (CI) were cal-
culated at the 95% level. Socio-demographic and symp-
tom data was presented using descriptive statistics:
distribution by age, number and percent of patients with
positive and negative results by transmission setting and
diagnostic method and prescribed drugs.
Ethical considerations
The study was approved by Makerere University School
of Public Health Higher Degrees Research and Ethics
Committee; and the Uganda National Council for
Science and Technology (Ref: HS 209). The study was
registered with the Clinicaltrials.gov (NCT00565071).
Results
Description of the sample
The study was carried out in 30 sub-county level gov-
ernment HCs. Each diagnostic arm had five HCs located
in an area of low malaria transmission and another five
in a setting of high transmission intensity. Overall, 102,
087 outpatients presenting with fever were enrolled.
This included 52, 116 (51%) in low and 49, 971 (49%) in
high transmission settings. Those enrolled in the pre-
sumptive arm were 23, 884, RDT 46, 131 and micro-
scopy arm 32, 072 (Figure 1). Of the patients enrolled
59, 876 (58.7%) were females and 26, 421 (25.9%) were
children under five years of age (Table 1). The median
age in years for children under-five was 1.7 [inter-quar-
tile range one to three years] and for those five years
and above was 22 [inter-quartile range 13-35 years].
Proficiency in conducting the test
One hundred and thirty three HC staff were trained for
the study. The staff included: 24 clinical officers, 13 nur-
sing officers, 15 enrolled/registered nurses, 30 midwives,
36 nursing assistants and 15 laboratory assistants. Clini-
cal officers have three years of pre-service training;
nurses/midwives have two, laboratory assistants two to
three years while nursing assistants have six to nine
months. Laboratory assistants had two to six years of
work experience. All cadres of staff had attended train-
ing in human immunodeficiency virus (HIV) counselling
and testing. Therefore, they were experienced in testing
HIV using whole blood on rapid test strips, devices or
cassettes that work on the same principle as malaria
RDTs. At this level of the health care services delivery
system the staff in the RDT arm mentioned that one
day of training is adequate, mainly focusing on practical
(preparation of test and interpretation of results). On
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Figure 1 Study profile.
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the first day, few staff especially nursing assistants had a
challenge in collecting blood for the RDT using a loop
in children under five years. However, they had gained
adequate skills by the end of the first week. In the
microscopy arm, all staff attended the practical session.
Although they were able to prepare a thick blood smear,
reading and interpretation of results was the responsibil-
ity of the laboratory personnel. Eight of the HCs (four in
each district) in the microscopy arm did not have elec-
tricity. They used natural light when scanning for
malaria parasites. In the remaining two HCs, black-out
was frequent and electricity as source of light for
malaria microscopy was unreliable.
Duration of outpatient visit
The effective average contact time of clinicians with feb-
rile outpatients (excluding time for investigation) was
11.4 min [95%CI: 11.1-11.7], and was similar in the
three arms (Table 2). The mean effective contact time
for malaria investigations was significantly shorter when
using RDT 7.6 min [95%CI: 7.1-8.0] compared to micro-
scopy 11.0 min [95%CI: 10.6-11.4]. On average, outpati-
ents spent about two and half hours to complete a HC
visit. However, the time spent accessing services in the
RDT arm 134.4 min [95%CI: 123.5-145.3] was not dif-
ferent from that of presumptive treatment, but
significantly shorter than when using microscopy 188.5
min [95%CI: 173.8-203.3].
Malaria test results
Overall, 64, 110 in the two intervention arms were
tested (Table 3). The proportions tested in the two
transmission settings were not statistically different [RR:
1.10; 95%CI: 0.87-1.40]. However, patients were 1.59
times more likely to have a malaria test done in the
RDT arm 44, 565 (96.6%) [95%CI: 93.8-99.4] compared
to the microscopy arm 19, 545 (60.9%) [95%CI: 47.9-
74.0], [RR: 1.59; 95%CI: 1.31-1.92]. Still patients were
more likely to be tested in the RDT arm compared to
microscopy arm in children under-five years of age [RR:
1.56; 95%CI: 1.20-2.02], patients five years and above
[RR: 1.59; 95%CI: 1.34-1.90], patients in low transmis-
sion area [RR: 1.45; 95%CI: 1.41-1.49] and in the high
transmission setting [RR: 1.71; 95%CI: 1.06-2.76].
Overall, 28, 289 (44.2%) [95%CI: 30.8-57.5] had a posi-
tive test result. In the low transmission setting, the pro-
portion of those who tested positive in the RDT arm
was 3, 313 (20.5%) [95%CI: 17.4-23.6] and microscopy
arm 1, 548 (14.0%) [95%CI: 11.2-16.7]. The proportion
of those testing positive in the RDT arm 19, 414 (68.6%)
[95%CI: 62.2-74.9] in the high transmission setting was
also significantly higher than in the microscopy arm 4,
Table 1 Selected characteristics of study sample
Characteristic Presumptive (%) [Int. range] RDT (%)
[Int. range]
Microscopy (%) [Int. range]
Level at the health delivery system Sub-county Sub-county Sub-county
Number of health centres per arm 10 10 10
Total enrolment 23884 46131 32072
Gender (female) 14239(59.6) 26613(57.8) 19024(59.3)
Children under-five years of age 5265(22.0) 12828(27.8) 8328(26.0)
Median age (in years)
< 5 years 2[1-3] 1.6[1-3] 1.7[1-3]
≥5 years 21[13-34] 23[14-35] 20[12-35]
Proportion with history of fever
< 5 years 2695(94.0) 3393(87.5) 4224(88.0)
≥5 years 5568(73.7) 11936(70.3) 9276(68.4)
Int. range = inter-quartile range, RDT = rapid diagnostic test
Table 2 Mean patient time (in minutes) at different points of seeking care at government health centres
Variable Presumptive
Mean[95%CI]
RDT
Mean[95%CI]
Microscopy
Mean[95%CI]
Overall
Mean[95%CI]
Contact with clinician 11.1[10.6-11.6] 11.9[11.3-12.5] 11.3[10.8-11.9] 11.4[11.1-11.7]
Contact for investigation N/A 7.6[7.1-8.0] 11.0[10.6-11.4] 9.3[8.9-9.6]
Waiting time for test results N/A 37.5[32.8-42.3] 123.9[105.9-142.0] 62.4[54.6-70.2]
Overall waiting time 135.6[123.0-148.2] 109.2[98.3-120.1] 156.1[141.4-170.9] 133.7[126.0-141.3]
Time spent at HC 143.8[131.2-156.4] 134.4[123.5-145.3] 188.5[173.8-203.3] 155.6[147.8-163.4]
CI = Confidence Interval, HC = health centre, N/A = not applicable, RDT = rapid diagnostic test
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014 (47.4%) [95%CI: 35.7-59.1]. Generally, the risk of
having a positive test was higher among children under-
five years of age 10, 900 (61.1%) compared to patients
five years old and above 17, 124 (37.4%) [RR: 1.62; 95%
CI: 1.41-1.86]. This relationship was maintained in the
low transmission area [RR: 1.12, 95%CI: 1.05-1.21], and
increased in the high transmission setting [RR: 1.29;
1.14-1.47].
Treatment of patients who did not receive a
parasitological diagnosis for malaria
All patients in the control arm were treated with anti-
malarials (Figure 1 and Table 4). Prescription of AL in
the control arm was not significantly different between
those under five years and the older age group. A total
of 12, 527 (39.1%) in microscopy and 1, 566 (3.4%) in
RDT arms were not tested [RR: 11.50; 95%CI: 5.16-
Table 3 Proportion of patients tested and malaria results by age and transmission intensity
Diagnostic method Low transmission High transmission
Enrolled Tested
n(%)
Positive
n(%)
Enrolled
n(%)
Tested
n(%)
Positive
n(%)
Presumptive
< 5 years 2936 - 2329 -
≥5 years 14035 - 4584 -
RDT
< 5 years 2716 2571(94.7) 583(22.7) 10112 10075(99.6) 7932(79.2)
≥5 years 14921 13624(91.3) 2730(20.1) 18382 18295(99.5) 11482(62.8)
Microscopy
< 5 years 2900 1768(61.0) 269(15.2) 5428 3502(64.5) 2122(60.6)
≥5 years 14608 9313(63.8) 1279(13.7) 9136 4962(54.3) 1892(38.1)
RDT = rapid diagnostic test
Table 4 Patients treated with artemether-lumefantrine stratified by diagnostic method, age and transmission intensity
Low transmission High transmission
Presumptive
n(%)
[95%CI]
Microscopy
n(%)
[95%CI]
RDT
n(%)
[95%CI]
Total
n(%)
[95%CI]
Presumptive
n(%)
[95%CI]
Microscopy
n(%)
[95%CI]
RDT
n(%)
[95%CI]
Total
n(%)
[95%CI]
Not tested
Age (yrs)
< 5 2932(99.9)
[99.7-100]
1103(97.4)
[95.6-99.2]
129(88.8)
[80.1-97.9]
4164(98.8)
[97.6-100]
2309(99.1)
[97.9-100]
1842(95.6)
[94.3-97.0]
33(89.2)
[78.6-99.7]
4184(97.5)
[95.6-99.3]
≥5 13999(99.7)
[99.6-99.8]
5163(97.5)
[96.5-98.4]
741(57.1)
[54.9-59.3]
19903(96.5)
[93.1-99.9]
4564(99.6)
[99.4-99.7]
3936(94.3)
[92.7-95.9]
62(71.3)
[61.5-80.9]
8562(96.8)
[94.1-99.5]
Total 16931(99.7)
[99.6-99.8]
6266(97.5)
[96.5-98.5]
870(60.3)
[57.9-62.8]
24067(96.9)
[93.9-99.8]
6873(99.4)
[99.0-99.8]
5778(94.7)
[93.5-95.9]
95(76.1)
[69.0-84.2]
12746(97.0)
[94.6-99.4]
Tested
Positive
Age (yrs)
< 5 N/A 264(98.1)
[95.2-100]
576(98.8)
[98.4-99.2]
840(98.6)
[97.8-99.4]
N/A 2106(99.3)
[97.8-100]
7853(99.0)
[97.6-100.]
9959(99.1)
[98.1-100]
≥5 N/A 1254(98.0)
[96.1-99.7]
2675(98.0)
[97.4-98.6]
3929(98.0)
[97.5-98.5]
N/A 1842(97.4)
[97.8-98.8]
11293(98.4)
[96.5-100]
13135(98.2)
[96.9-99.5]
Total N/A 1518(98.1)
[96.9-99.2]
3251(98.1)
[97.6-98.7]
4769(98.1)
[97.7-98.5]
N/A 3948(98.4)
[96.9-99.7]
19146(98.6)
[96.9-100]
23094(98.6)
[97.4-99.7]
Negative
Age (yrs)
< 5 N/A 374(25.0)
[21.6-28.3]
332(16.7)
[11.2-22.2]
706(20.3)
[16.1-24.4]
N/A 1138(82.5)
[80.4-84.5]
1246(59.6)
[57.5-61.8]
2384(68.7)
[44.0-93.4]
≥5 N/A 1630(20.3)
[16.4-24.2]
1413(13.0)
[12.4-13.6]
3043(16.1)
[11.7-20.5]
N/A 2298(74.9)
[73.3-76.4]
2055(30.2)
[29.1-31.3]
4353(44.1)
[40.2-48.9]
Total N/A 2004(21.0)
[17.4-24.7]
1745(13.6)
[12.9-14.2]
3749(16.8)
[12.4-21.1]
N/A 3436(77.2)
[75.9-78.4]
3301(37.1)
[36.1-38.1]
6737(50.5)
[43.1-55.4]
CI = confidence interval, N/A = not applicable, RDT = rapid diagnostic test
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25.65]. Subsequently, 12, 044 (96.1%) and 965 (61.6%)
respectively were treated with AL.
Treatment of patients with a positive RDT or microscopy
All patients in both microscopy and RDT arms with
positive results received anti-malarial treatment (Figure
1). Overall, parasitological confirmation of malaria was
associated with a reduction in the prescription of AL
between presumptive and RDT [RR: 0.62; 95%CI: 0.47-
0.82], and between presumptive and microscopy [RR:
0.72; 95%CI: 0.60-0.86].
Treatment of patients with negative RDT or microscopy
results
Overall, 10, 558 (29.5%) were treated with AL. Patients
with RDT negative results were more often prescribed
AL in the high transmission setting 3, 301 (37.1%) com-
pared to those in the low transmission area 1, 744
(13.6%) [RR: 2.74; 95%CI: 1.05-7.15]. In the microscopy
arm, there was a two to five-fold likelihood of prescrib-
ing AL to patients with negative results in the high
transmission area 3, 436 (77.2%) than in the low trans-
mission setting 2, 002 (21.0%) [RR: 3.67; 95%CI: 2.43-
5.54]. This implies that the likelihood of not accepting
negative microscopy results was higher than that for
RDT in a setting of high malaria transmission.
Within the low transmission setting, children under-
five years of age with negative microscopy results were
more often prescribed AL compared to those in the
RDT arm [RR: 1.49; 95%CI: 1.14-1.97]. A similar pattern
in AL prescription was observed among patients five
years and above. In the high transmission setting there
was no statistically significant difference in AL prescrip-
tion among children under-five years when those treated
under microscopy were compared to those under RDT.
Among patients five years and above in the high trans-
mission setting 2, 055 (30.2%) in the RDT arm and 2,
298 (74.9%) in microscopy arm were prescribed AL [RR:
2.48; 95%CI: 0.83-7.41].
Discussion
This study provides data on the comparative feasibility
of microscopy and RDT among outpatients attending
government rural primary health care centres located
within areas of varying transmission intensities. The
study findings indicate that RDT was more feasible than
microscopy and prescribers were unlikely to adhere to
negative results especially in the microscopy arm.
It is reported here that patients attending HCs with
RDT as the method for malaria investigation had a
higher probability of getting a parasitological test done
regardless of age and transmission setting. Out of 133
clinical and laboratory staffs trained in 30 HCs, 56 were
in the RDT arm and they performed the testing of
patients during the whole period of study implementa-
tion. In the microscopy arm, the staff either had clinical
or laboratory roles, although clinicians were able to pre-
pare usable thick smears. Microscopy was the sole
responsibility of the laboratory assistants. This meant
that the RDT diagnostic services were not interrupted
even if the laboratory assistants were away on leave. Per-
forming RDT takes a much shorter time than micro-
scopy. Therefore given a similar time, more patients
could be tested in RDT compared to microscopy. RDTs
reduced the patient waiting time compared to micro-
scopy and were thus more convenient for health work-
ers and patients. An earlier investigation [21] also
reported a high number of patients tested by RDT.
However, that study did not have a microscopy arm and
therefore constraining a full comparison with the cur-
rent findings. In Tanzania, a study that introduced rou-
tine use of malaria RDTs only resulted into 35% of
patients being tested [22].
The risk of a febrile patient not getting a malaria diag-
nostic service was higher in HCs with microscopy and
even far higher among patients under-five years of age.
The current malaria treatment policy in Uganda and
WHO [1] recommend that malaria case diagnosis be
based on parasitological confirmation either by micro-
scopy or RDT. An earlier publication reported a short-
age of staff where only 34% of laboratory assistant posts
were filled, although only four HCs had functioning
laboratories at the time [16]. In order to improve the
availability of microscopy services, there is need to func-
tionalize the laboratories and to train and post at least
two laboratory assistants at each HC. The low rate of
malaria tests done in the microscopy arm adds to pre-
vious reports [13-15,23] regarding the microscopy lim-
itations, signifying the difficulties surrounding its
feasibility and scale up of the service.
With routine use of parasitological confirmation of
malaria, prescription of AL was reduced by 28.1%
between presumptive and microscopy; and by 38%
between presumptive and RDT. This benefit was also
reported in other studies [21,24], but it was offset by
continued prescription of AL to patients with negative
results. Indeed treatment of this “negative syndrome”
with AL is a cause for concern in both intervention
arms, and it was significantly higher in the microscopy
arm in both transmission settings and age groups. This
might imply prescribers were unlikely to adhere to nega-
tive microscopy results. Prescribing anti-malarials
among patients with negative results has also cited
[2-4,9,21,22,25-27]. The behaviour of treating negative
patients with AL may reflect the hangover of previous
practices of presumptive treatment, doubting accuracy
of test methods, patients having been on anti-malarials
before, or clinicians not knowing how to treat patients
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with negative results due to lack of clear guidelines. The
continuous prescription of anti-malarials by clinicians
disregarding negative test results is likely to impact on
the cost-effectiveness of the diagnostic methods, clinical
care of patients as well as increasing the costs of diagno-
sis and that of the overall treatment. Furthermore if
negative patients continue receiving anti-malarials,
health workers are more likely not to see the need for
parasite-based diagnosis and may not be motivated to
implement the policy. Therefore, service providers need
support and guidelines on how to manage patients with
negative results.
In the preparation for the study, RDTs, AL and
laboratory supplies were delivered by the study team to
the district medical stores. However, AL stock-out
occurred in the high transmission setting that resulted
into a reduction in the number of outpatient attendance.
Subsequently this impacted on the number of patients
enrolled in the high transmission setting. RDTs were in-
stock throughout the study implementation period. The
training of staff for this study took one day. However,
other cadres of staff without such skills as HIV testing
might require slightly longer period (three to five days).
To acquire adequate skills for example in testing malaria
with RDT, it is important to make frequent supervisory
visits and tapering the number of visits with time. In
this study, it was planned to have three diagnostic arms
(presumptive, RDT and microscopy). Further research
should consider incorporating the arm of RDT plus
microscopy.
Conclusion
RDT was more feasible than microscopy and patients
with negative results received significantly more AL in
the microscopy arm compared to those in the RDT arm.
To realise the benefits of parasitological confirmation of
malaria, service providers need to adhere to test results
and they need guidance regarding management of
patients with negative results.
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